1. Home
  2. PLX vs ALCO Comparison

PLX vs ALCO Comparison

Compare PLX & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

N/A

Current Price

$2.88

Market Cap

230.0M

Sector

Health Care

ML Signal

N/A

Logo Alico Inc.

ALCO

Alico Inc.

N/A

Current Price

$37.94

Market Cap

267.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PLX
ALCO
Founded
1993
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.0M
267.7M
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
PLX
ALCO
Price
$2.88
$37.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
1.4M
22.1K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
0.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,399,000.00
N/A
Revenue This Year
$9.67
N/A
Revenue Next Year
$23.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$27.50
52 Week High
$3.19
$43.20

Technical Indicators

Market Signals
Indicator
PLX
ALCO
Relative Strength Index (RSI) 54.84 31.12
Support Level $1.39 $31.59
Resistance Level $3.11 $38.40
Average True Range (ATR) 0.15 1.17
MACD -0.05 -0.44
Stochastic Oscillator 49.59 15.07

Price Performance

Historical Comparison
PLX
ALCO

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: